Newness of drugs and use of HMO services by asthma patients

Annals of Pharmacotherapy

Volumn 35, Issue 9, 2001, Pages 990-996

  Horn, Susan D ^a   Sharkey, Phoebe D ^b   Kelly, H William ^c   Uden, Donald L ^d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON   (United States)

^b LOYOLA UNIVERSITY MARYLAND   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Asthma; Drug product technology; Health maintenance organizations

Indexed keywords

ADRENALIN; ANTIASTHMATIC AGENT; BECLOMETASONE DIPROPIONATE; BITOLTEROL MESILATE; CROMOGLYCATE DISODIUM; DEXAMETHASONE SODIUM PHOSPHATE; DIPROPHYLLINE; FLUNISOLIDE; IPRATROPIUM BROMIDE; ISOETARINE; ISOPRENALINE; NEW DRUG; ORCIPRENALINE; PIRBUTEROL; SALBUTAMOL; SALBUTAMOL SULFATE; TERBUTALINE; TERBUTALINE SULFATE; TERFENADINE; THEOPHYLLINE; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; DISEASE SEVERITY; DRUG APPROVAL; DRUG COST; EMERGENCY WARD; FEMALE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE UTILIZATION; HEALTH MAINTENANCE ORGANIZATION; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; TECHNOLOGY;

ADULT; AGED; AMBULATORY CARE; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; COST CONTROL; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HOSPITALIZATION; HUMANS; MALE; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; TECHNOLOGY, PHARMACEUTICAL; UNITED STATES;

EID: 0034829938     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10241     Document Type: Article

References (16)

1. The effect of pharmaceutical utilization and innovation on hospitalization and mortality
2. Inhaled steroids and the risk of hospitalization for asthma
3. National Asthma Education and Prevention Program working group report on the cost effectiveness of asthma care
4. Effect of including both physicians and pharmacists in an asthma drug-use review intervention
5. Low-dose inhaled corticosteroids and the prevention of death from asthma
6. The use of beta-agonists and the risk of death and near death from asthma
7. Pharmacist-managed, physician directed asthma management program reduces emergency department visits
8. Educational and long-term therapeutic intervention in the ED: Effect on outcomes in adult indigent minority asthmatics
9. Intended and unintended consequences of HMO cost-containment strategies: Results from the Managed Care Outcomes Project
10. Managed Care Outcomes Project: Study design, baseline patient characteristics, and outcome measures
11. Formulary limitations in the elderly: Results from the Managed Care Outcomes Project
12. The impact of pharmaceutical capitation to primary medical groups on the health care expenditures of Medicare HMO enrollees
13. Explaining drug spending trends: Does perception match reality?
14. Using pharmaceutical marketing data to determine the national impact of guidelines on the management of asthma